Survey of pharmacist-managed inpatient anticoagulation services

American Journal of Health-System Pharmacy

Volumn 64, Issue 21, 2007, Pages 2275-2278

  Phillips, Katherine W ^a   Wittkowsky, Ann K ^b,c  

^a BOSTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Anticoagulants; Argatroban; Bivalirudin; Data collection; Fondaparinux; Heparin; Lepirudin; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital; Protocols; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; FONDAPARINUX; HEPARIN; LEPIRUDIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PRACTICE; DRUG USE; E-MAIL; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; PATIENT CARE; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 36048968860     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070213     Document Type: Article

References (13)

1. Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:265S-286S.
2. Smythe MA. Advances in anticoagulation management: the role of pharmacy. Ann Pharmacother. 2007; 41:493-5.
3. U.S. Pharmacopeia. Top 50 drug products associated with medication errors. www.usp.org/patientSafety/resources/top50DrugErrors.html (accessed 2007 Mar 29).
4. Joint Commission. Potential 2008 national patient safety goals and requirements: ambulatory care version. www.jointcommission.org/NR/rdonlyres/ 99D7EA58-C758-415E-8DA4-CD83EA6C591C/0/08_potential_AHC_NPSG.pdf (accessed 2007 Mar 18).
5. Ansell J, Hirsch J, Poller L et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:204S-233S. [Erratum, Chest. 2005;127:415-6.]
6. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004; 24:953-63.
7. Dager WE, Brach JM, King JH et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother. 2000;34:567-72.
8. Holden K, Harris L, Prescott R. Effectiveness of inpatient oral anticoagulation management: comparison of pharmacists with junior medical staff. Int J Pharm Pract. 2003; 11:R60.
9. Mamdani MM, Racine E, McCreadie S et al. Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy. 1999; 1064-74.
10. Donovan JL, Drake JA, Whittaker P et al. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis. 2006; 22:23-30.
11. Kaboli PJ, Hoth AB, McClimon BJ et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166:955-64.
12. Joint Commission. National consensus standards for prevention and care of venous thromboembolism (VTE). www.jointcommission.org/PerformanceMeasurement/ Performance Measurement/VTE.htm (accessed 2007 Jul 25).
13. Colorado Foundation for Medical Care. Surgical Care Improvement Project (SCIP). www.cfmc.org/hospital/hospital_scip.htm (accessed 2007 Mar 18).